Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
If you’re looking for growth in your portfolio, you may have considered ResMed Inc (ASX: RMD) or Ramsay Health Care Limited (ASX: RHC). Here’s which one I would pick.
ResMed Inc (ASX:RMD) announced the fourth quarter result of its 2019 financial year.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.32% at lunch.
The BetaShares Global Sustainability Leaders ETF (ASX:ETHI) and the BetaShares Australian Sustainability Leaders ETF (ASX:FAIR) are two options.
The healthcare industry benefits from an ageing population. I look at two ASX shares, ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL).
The 52-week high price for Cochlear Limited (ASX: COH) shares is $221.44. Up almost 20% in the last three months, could Cochlear reach these highs again?
Forget CSL shares, Cochlear Ltd (ASX: COH), Nanosonics Ltd (ASX:NAN) and ResMed Inc (ASX:RMD) shares are amongst my top three ASX healthcare shares.
The ResMed Inc. (ASX:RMD) share price is up as much as 10.5% to a high of $16.25 after handing down the third quarter results with revenue up 12%.
ResMed Inc (ASX:RMD) shares and TPG Telecom Ltd (ASX:TPM) shares are two ASX blue-chips that have seen steep drops recently.
